Tata Consultancy Services (TCS), a leading global IT services, consulting and business solutions organization, has been named a Leader in Everest Group's Services PEAK Matrix™ 2018 for Life Sciences Digital Services in North America.

The PEAK MatrixTM positioned TCS the highest for market impact, listing its digital transformation capabilities, consistency of performance and next-generation digital solutions-such as the Advanced Drug Development Platform that uses artificial intelligence and loT for drug development and patient engagement-as key strengths.

"Life sciences companies are accelerating their digital transformation journeys in pursuit of their growth agenda, embracing AI for drug discovery and development, cloud for data management, and automation and loT for connected health," said Debashis Ghosh, President- Life Sciences and Healthcare, TCS. "Our Leader position is a validation of our vision and ability to leverage the Business 4.0 thought leadership framework for those transformation journeys and the resultant market success that we are seeing."

TCS partners with leading life sciences companies in leveraging next generation platforms and emerging technologies to drive innovation, gain speed-to-market and drive internal efficiencies. The company offers a full set of digital transformation services and solutions including consulting, predictive and prescriptive analytics, genomics research, advanced platform solutions and cognitive business operations. Early investments in building capabilities in digital technologies in the form of reskilling the workforce, agile workplaces and intellectual property have helped TCS gain significant scale and depth in the digital space.

Shares of the company declined Rs 24.45, or 1.24%, to settle at Rs 1,950.65. The total volume of shares traded was 105,699 at the BSE (Thursday).